Navigation Links
Merrimack Pharmaceuticals Promotes Ulrik B. Nielsen, Ph.D. to Chief Scientific Officer and Edward J. Stewart to Senior Vice President of Business Development
Date:3/9/2009

CAMBRIDGE, Mass., March 9 /PRNewswire/ -- Merrimack Pharmaceuticals, Inc., a privately held biotechnology company focused on the discovery and development of novel treatments for cancer and autoimmune disease, today announced that Ulrik B. Nielsen has been promoted to Senior Vice President and Chief Scientific Officer and Edward (Tad) J. Stewart to Senior Vice President of Business Development.

"Ulrik and Tad have both played critical roles in building Merrimack into the fully integrated and clinically diversified research and development company that we are today," said Robert Mulroy, President and CEO of Merrimack. "Merrimack is at the forefront of the systems biology field with a robust pipeline of biologics in large part due to the dedication and innovation that Ulrik brings to building integrated, predictive medicines through the use of Network Biology and Tad's expertise in establishing the collaborations and intellectual property foundation to drive our business."

In his new position, Dr. Nielsen, a founder of Merrimack who has been with the Company since inception, continues to be responsible for the strategic direction of the Company's research, early stage pipeline products, new project ideas and discovering and encouraging innovative techniques of integrating the Network Biology platform into therapeutic development from discovery stage through to the clinic. Prior to joining Merrimack, Dr. Nielsen was a post-doctoral fellow in Dr. Peter Sorger's laboratory at the Massachusetts Institute of Technology, where he researched the interface among biology, engineering, and computational biology. Dr. Nielsen received his Ph.D. from the University of Copenhagen in molecular biology and received Master's and Bachelor's degrees in biochemistry from the University of Copenhagen.

Mr. Stewart's, who has been with the Company sinc
'/>"/>

SOURCE Merrimack Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Merrimack Pharmaceuticals Announces the Addition of Robert Gay to its Board of Directors
2. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
3. Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1 Study of MM-121, an ErbB3 Antagonist
4. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
5. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
6. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Ga. , Aug. 26, 2014  ViveBio, ... biological sample collection, stabilization and transportation, announced today ... Laboratory Procurement Services, LLC (LPS) of ... of products in the United States ... new class of ambient temperature dried biological specimen ...
(Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:8/26/2014)... WASHINGTON , Aug. 26, 2014 ... Next Generation Dx Summit; Moving Assays to ... "Targeted Detection and Monitoring of Cell Free Tumor ... the analytical component of its Precision Cancer Monitoring ... high clinical sensitivity for the detection of tumor ...
(Date:8/26/2014)... 2014  That,s Nice LLC, a research-focused strategic marketing ... formation of a new dedicated team that will support ... will combine current and new staff in both market ... Guy Tiene has been hired ... Tiene was previously Director of Marketing for Royal DSM,s ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3
... Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central nervous system disorders, today announced ... December 31, 2008. Vanda reported a net loss ... compared to $10.9 million for the third quarter of ...
... Development Conference features presentations from industry and academic speakers who ... and chemical industries. Topics include Chemical and Process R&D, ... by Design (QbD). , ... Columbia, ...
... New Mexico, February 10, 2009A team of Los Alamos ... multiplicationwhen a photon creates multiple electronsis a real phenomenon ... born of extraneous effects that mimic carrier multiplication. The ... of Chemical Research , shows the possibility of solar ...
Cached Biology Technology:Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 3Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 4Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 5Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 6Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 7Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 8Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 9Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 1016th International Process Development Conference to be Held June 14-17, 2009 in Arosa, Switzerland 2Research highlights potential for improved solar cells 2Research highlights potential for improved solar cells 3
(Date:8/26/2014)... New Zealand endemic tree has for the last 31 years ... Australian shrubs and small trees. A New Zealand botanist has ... astonishing cryptic diversity behind what was long considered a single ... journal PhytoKeys . , Known to botanists ... the many discoveries made in the north-western South Island of ...
(Date:8/26/2014)... assistant professor of mathematical sciences at New Jersey Institute ... into the biological clock that sets the pace for ... humans and all other mammals with fundamental rhythms of ... experienced each day and with seasonal change. The brain,s ... of sleep/wake behavior which, when disrupted by experiences such ...
(Date:8/26/2014)... social problems such as global warming and poverty ... the burden fall on our failure as consumers ... new study in the Journal of Consumer ... solving global problems from governments to consumers and ... businesses convince politicians to encourage responsible consumption instead ...
Breaking Biology News(10 mins):And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3Researching fundamental rhythms of life 2Researching fundamental rhythms of life 3An inconvenient truth: Does responsible consumption benefit corporations more than society? 2
... energy or one that,s environmentally destructive? That,s the question ... Society Forum session on fracking April 10, 2013 from 3 ... NJIT Technology and Society Forum is free and open to ... underground at high pressure to fracture rock formations in order ...
... yet available to build a comprehensive map of the activity ... world the human brain, scientists say in a newly ... and developed for the Brain Activity Mapping (BAM) Project, which ... Project did for genetics. Published in the journal ...
... prey, most of us picture stealthy lions and restless gazelle, ... But Ben Baiser, a post-doctoral fellow at the Harvard Forest ... , thinks on a more local scale. His inter-species drama ... North America, home to the carnivorous pitcher plant, Sarracenia ...
Cached Biology News:Fracking: Challenges and opportunities 2Brain Activity Mapping Project aims to understand the brain 2An inside look at carnivorous plants 2
NATIVE RAT OSTEOCALCIN...
Form: Ready to use Applications: ELISA...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Wnt-1 (G-19)...
Biology Products: